Auraptene and Other Prenyloxyphenylpropanoids Suppress Microglial Activation and Dopaminergic Neuronal Cell Death in a Lipopolysaccharide-Induced Model of Parkinson’s Disease

By Okuyama Satoshi   Semba Tomoki   Toyoda Nobuki   Epifano Francesco   Genovese Salvatore   Fiorito Serena   Taddeo Vito Alessandro   Sawamoto Atsushi   Nakajima Mitsunari   Furukawa Yoshiko  

International Journal of Molecular Sciences, Vol. 17, Iss. 10, 2016-10 ,pp. : 1716-1716

MDPI

Access to resources Recommend Favorite

Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa–Induced Dyskinesia in Parkinson’s Disease

By Comi Cristoforo   Ferrari Marco   Marino Franca   Magistrelli Luca   Cantello Roberto   Riboldazzi Giulio   Bianchi Maria Laura Ester   Bono Giorgio   Cosentino Marco  

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-01 ,pp. : 242-242

MDPI

Access to resources Recommend Favorite

Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization

By  

JOURNAL OF NEUROSCIENCE RESEARCH, Vol. 93, Iss. 5, 2015-05 ,pp. : 755-765

John Wiley & Sons Inc

Access to resources Recommend Favorite

Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson’s Disease in Rats

By Chen Guangxin   Liu Juxiong   Jiang Liqiang   Ran Xin   He Dewei   Li Yuhang   Huang Bingxu   Wang Wei   Fu Shoupeng  

International Journal of Molecular Sciences, Vol. 19, Iss. 1, 2017-12 ,pp. : 12-12

MDPI

Access to resources Recommend Favorite

Zonisamide reduces nigrostriatal dopaminergic neurodegeneration in a mouse genetic model of Parkinson's disease

By  

JOURNAL OF NEUROCHEMISTRY (ELECTRONIC), Vol. 134, Iss. 2, 2015-07 ,pp. : 371-381

John Wiley & Sons Inc

Access to resources Recommend Favorite